Aegera Therapeutics Inc.
Verdun, QC
Company Overview
Aegera Therapeutics Inc. is a private North American biotechnology company focused on exploiting apoptosis control to extend and enhance life: killing cancer cells by inducing apoptosis and protecting nerve cells from chemotherapy-induced death. Aegeras lead oncology program is a XIAP antisense herapeutic which will enter the clinic in Q1 2004. A second oncology program, the AEG3482 Small Molecule Series, is scheduled to enter clinical trials in late 2004, to treat hemotherapy-induced neuropathy, the largest remaining untreated side effect suffered by cancer patients.
Company Information
Physical Address
810, ch. du Golf
Verdun, QC H3E 1A8
CA
Mailing Address
810, ch. du Golf
Verdun, QC H3E 1A8
CA
Additional Details
Legal Name: Aegera Therapeutics Inc.
Number of Employees: 40
CA
More details available upon request.
Contacts
Michael Atkin
Title: Chief Executive Officer
Area of Responsibility: Management Executive
Phone: Show phone
Fax: Show fax
Email: Show email
Services
- Biotechnology
- Research & Development
Additional Information
541710